Topricin serves up more sizes for foot therapy cream
Topical BioMedics Inc. has added two new sizes for its all-natural Topricin Foot Therapy Cream, which was introduced last year.
Supplier News
Mylan rolls out minocycline ER tablets
Mylan Pharmaceuticals Inc. has started shipment of minocycline hydrochloride extended-release tablets, indicated for the treatment of acne.
VEET campaign aims to spur customer trials
Reckitt Benckiser’s VEET depilatory brand has launched the "Get Your VEET On Challenge," in which consumers are encouraged to try the new VEET Suprem’Essence products for a weekend and share their experiences for a chance to win prizes.
Bayer Diabetes A1C devices meet tighter criteria
Bayer Diabetes Care’s A1CNow+ and A1CNow SELFCHECK diabetes testing devices have been certified to meet tighter performance guidelines instituted by the National Glycohemoglobin Standardization Program (NGSP).
Caraco markets generic version of Flomax
Caraco Pharmaceutical Laboratories Ltd. has begun shipping tamsulosin hydrochloride capsules, a medication for men with an enlarged prostate. The company said Thursday that the product was recently approved by the Food and Drug Administration for Sun Pharma’s abbreviated new drug application (ANDA).
TCGRx launches pharmacy will-call system
TCGRx has rolled out Will-Call Rx, a computerized system for hanging and retrieving will-call prescriptions that’s designed to ensure accurate medication pickup.
Reckitt Benckiser to buy SSL International
Reckitt Benckiser Group has reached an agreement to acquire SSL International, the maker of Durex condoms and Scholl foot care products. The companies said Wednesday that Reckitt Benckiser has agreed to pay 2.54 billion pounds ($3.9 billion) to buy SSL.
American Greetings unveils ‘Open This When’ cards
American Greetings has launched a new greeting card line that’s designed to convey a lasting, more meaningful message by providing a special note for later.
Carmex launches new skin care line
Carma Laboratories Inc., the maker of Carmex lip balm products, has unveiled a new skin care product line, Carmex Healing Lotion and Carmex Healing Cream. The company said Tuesday that the new line marks the first time that it has expanded its product offerings beyond lip balm.
Mylan releases generic patch for hypertension
Mylan Inc. has begun shipping a generic clonidine patch for treating high blood pressure. The drug maker said Monday that its Mylan Technologies Inc.
McKesson named Walmart supplier of the year
McKesson Corp. said it has been recognized by Walmart as one of the retail giant’s best-performing suppliers in 2009.
Cardinal closes Healthcare Solutions acquisition
Cardinal Health Inc. has finalized its acquisition of Healthcare Solutions Holding LLC. The pharmaceutical and health care products distributor announced the $517 million cash deal early last month, saying that the agreement would expand the company’s presence in specialty pharmaceutical services.
Panel delivers split decision on Avandia
An advisory committee to the Food and Drug Administration has recommended that GlaxoSmithKline PLC’s (GSK) diabetes drug Avandia should remain on the market, but possibly with tough new restrictions and new warnings.
Carlyle Group to buy NBTY for $3.8 billion
Dietary supplements supplier NBTY Inc. has agreed to be purchased by private equity firm Carlyle Group for $3.8 billion in one of the biggest private equity deals thus far in 2010. Carlyle’s $55 a share cash offer is 47% above NBTY’s stock close on Wednesday. NBTY announced the deal a day after
PhRMA picks new president, CEO
Pharmaceutical Research and Manufacturers of America (PhRMA) has named John Castellani its new president and chief executive officer, effective September 1.
Merck to eliminate eight research facilities
Merck & Co. is planning to phase out operations at eight research sites and eight manufacturing sites. It is also continuing to consolidate office facilities worldwide as part of the global merger restructuring program that began last December following its acquisition of Schering-Plough Corp.